Current Reports (Form 8-K)

1,401,941 filings since 2004 · latest accepted Nov 4, 2026, 6:03 AM ET

Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.

Filed	Company	Items	Filing
Apr 2, 2026 accepted 8:19 PM ET	PMCBPharmaCyte Biotech, Inc.	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
Oct 31, 2025 accepted 8:05 PM ET	PMCBPharmaCyte Biotech, Inc.	Officer / director change

Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.